A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer
about
Common variants of the vitamin D binding protein gene and adverse health outcomesVitamin D pathway gene variants and prostate cancer prognosisHow strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causalityPolymorphisms in vitamin D metabolism related genes and risk of multiple sclerosisVitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological EvidenceVitamin D and Immune Response: Implications for Prostate Cancer in African AmericansFat Intake Is Not Linked to Prostate Cancer: A Systematic Review and Dose-Response Meta-AnalysisCirculating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidencesPigmentation and vitamin D metabolism in Caucasians: low vitamin D serum levels in fair skin types in the UKPretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1.The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men.Cancer risks in a population-based study of 70,570 agricultural workers: results from the Canadian census health and Environment cohort (CanCHEC)In older men, lower plasma 25-hydroxyvitamin D is associated with reduced incidence of prostate, but not colorectal or lung cancer.Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialPrediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.Vitamin D deficiency predicts prostate biopsy outcomes.Vitamin D deficiency and insufficiency among patients with prostate cancerPlasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.Indoor ultraviolet tanning and skin cancer: health risks and opportunities.Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination SurveyVitamin d status is not associated with outcomes of experimentally-induced muscle weakness and pain in young, healthy volunteers.Natural and engineered nicking endonucleases--from cleavage mechanism to engineering of strand-specificityPrevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease.Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue.Rediscovering vitamin DVitamin D as a promising anticancer agentThe benefits and risks of ultraviolet tanning and its alternatives: the role of prudent sun exposure.Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.Vitamin d, sunlight and prostate cancer riskSerum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaPSunlight exposure, vitamin D, and risk of non-Hodgkin lymphoma in the Nurses' Health Study.Milk intake in early life and risk of advanced prostate cancer.Vitamin D status during pregnancy and aspects of offspring health.Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control studyDeterminants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohorts
P2860
Q24596671-4CB63D2F-68BF-467C-8BBB-BCAE45F8D0C7Q24628345-0746DB5B-0241-4F93-9EA8-624E6DC9F0ECQ24645200-04428821-F50B-4109-A9F9-778836AC4483Q24650192-04691D86-C4BA-46E5-A15A-4B20F234E1FBQ26766256-87A83517-5816-4E26-B69B-8CAE00ADE5A6Q26768536-2697B0BD-D364-495E-A96B-A98A49A872EFQ26799504-3937861F-7495-4F72-853E-BEC45FFA984BQ27336054-D8805684-E6FE-45F8-8B04-2D6DD2F8D6D1Q30234898-4AA393B8-6CB2-48C9-A956-A18CEFAD4C1EQ30871474-447F0D3F-07CC-467A-8B98-C148E31BD7F5Q31001849-D50C8709-62D7-4888-82AB-0EFEBB034826Q33523626-528E5F90-A4B6-4AB9-8B9E-CAB370F10111Q33577607-AF76AD11-9741-4255-9495-273A51350CB3Q33601272-1B5D76AB-FC71-4CD5-B9FD-BDBEFE52DC02Q33706184-3C9BD46F-318D-4B78-B103-81EA66F73B4CQ33783979-6D4F30A8-9060-4E67-9214-8B7F785D5B50Q33803855-EF20A07C-F82C-46B5-868F-028C8986031BQ33873649-35F8F5E0-E176-49F3-BD9D-116A384D701CQ33923335-D6D0663F-14C9-40B0-9EB6-F2BFF3D008DFQ33927888-BCA9608F-020D-4F82-B008-CE915DD0A6E5Q33992150-0BBA8EB3-6DAE-46E3-8945-36598B87734BQ34018094-A0DFA7AD-321D-4221-ACBD-7543994C4566Q34115732-C1EFAF30-D2D4-432B-BECC-0C83F5F31A7FQ34131771-D5384972-0097-426C-A56A-CF0FC2645B84Q34442866-0EE48987-4972-4DB2-9CD8-9E6A50F39709Q34474076-3E6DA44C-EC50-473A-9B8A-B9827AD82B36Q34598371-354896DB-02EF-4F72-9037-974A074369B5Q34624695-1DD5C79F-8A07-46C2-9855-A81BDEA4D429Q34736323-B7C6A09A-D7A5-42C3-A707-E3384A3A1805Q34843911-199ABBDC-64C1-41B9-9998-3D86B0B6EDCFQ34955203-9B8DD3F9-B584-420D-9BAF-DFA812C3B3E2Q35023459-6ED1A1F0-F710-40B8-B602-5FEE943FF26EQ35207472-D22308F0-766A-48DE-915A-E56CAF3C59C0Q35286318-98C2E080-88E6-45D4-86A4-6F34FFC6D91EQ35546959-A9696D31-93BC-44DE-9254-AA7118E7ED0BQ35619687-D4C4F510-E5C5-459E-9E01-9D54A6E1C58FQ35644936-87D4111A-941E-490C-A2CE-57E16AC4779AQ35670905-39F11D08-24BF-4DB2-923F-92B87C8E44A5Q35925515-E4B78A26-B5FE-45A9-8B33-E9CF0287DDC0Q35942077-2DBDA20B-5122-40E4-B42C-8B1B87547332
P2860
A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A prospective study of plasma ...... morphisms, and prostate cancer
@ast
A prospective study of plasma ...... morphisms, and prostate cancer
@en
A prospective study of plasma ...... morphisms, and prostate cancer
@nl
type
label
A prospective study of plasma ...... morphisms, and prostate cancer
@ast
A prospective study of plasma ...... morphisms, and prostate cancer
@en
A prospective study of plasma ...... morphisms, and prostate cancer
@nl
prefLabel
A prospective study of plasma ...... morphisms, and prostate cancer
@ast
A prospective study of plasma ...... morphisms, and prostate cancer
@en
A prospective study of plasma ...... morphisms, and prostate cancer
@nl
P2093
P2860
P50
P1433
P1476
A prospective study of plasma ...... morphisms, and prostate cancer
@en
P2093
J Bruce W Hollis
J Michael Gaziano
P2860
P356
10.1371/JOURNAL.PMED.0040103
P407
P577
2007-03-01T00:00:00Z